Henry Schein Stock Today

HSIC Stock  USD 75.82  1.82  2.34%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Henry Schein is trading at 75.82 as of the 26th of February 2025, a 2.34 percent decrease since the beginning of the trading day. The stock's open price was 77.64. Henry Schein has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Note, on October 8, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Henry Schein's common stock.
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York. The company has 124.17 M outstanding shares of which 5.77 M shares are currently shorted by private and institutional investors with about 4.31 trading days to cover. More on Henry Schein

Moving together with Henry Stock

  0.67GH Guardant HealthPairCorr
  0.81ALC Alcon AGPairCorr

Moving against Henry Stock

  0.49EMBC Embecta CorpPairCorr
  0.46DHR DanaherPairCorr
  0.39HAE HaemoneticsPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Henry Stock Highlights

Executive CEOStanley CPA
Thematic IdeaMacroaxis Index (View all Themes)
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, SP 500 Index, Nasdaq 100 Total, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Macroaxis Index, Health Care, Health Care Providers & Services, Medical Distribution, Healthcare (View all Sectors)
Henry Schein (HSIC) is traded on NASDAQ Exchange in USA. It is located in 135 Duryea Road, Melville, NY, United States, 11747 and employs 26,000 people. Henry Schein is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.64 B. Henry Schein conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 124.17 M outstanding shares of which 5.77 M shares are currently shorted by private and institutional investors with about 4.31 trading days to cover. Henry Schein currently holds about 123 M in cash with 500 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.91.
Check Henry Schein Probability Of Bankruptcy
Ownership Allocation
The majority of Henry Schein outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Henry Schein to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Henry Schein. Please pay attention to any change in the institutional holdings of Henry Schein as this could imply that something significant has changed or is about to change at the company. On October 8, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Henry Schein's common stock.
Check Henry Ownership Details

Henry Schein Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Henry Schein market risk premium is the additional return an investor will receive from holding Henry Schein long position in a well-diversified portfolio.

Henry Stock Against Markets

Henry Schein Corporate Executives

Elected by the shareholders, the Henry Schein's board of directors comprises two types of representatives: Henry Schein inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Henry. The board's role is to monitor Henry Schein's management team and ensure that shareholders' interests are well served. Henry Schein's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Henry Schein's outside directors are responsible for providing unbiased perspectives on the board's policies.
When determining whether Henry Schein offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Henry Schein's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Henry Schein Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Henry Schein Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Henry Schein. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For information on how to trade Henry Stock refer to our How to Trade Henry Stock guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Henry Schein. If investors know Henry will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Henry Schein listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Henry Schein is measured differently than its book value, which is the value of Henry that is recorded on the company's balance sheet. Investors also form their own opinion of Henry Schein's value that differs from its market value or its book value, called intrinsic value, which is Henry Schein's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Henry Schein's market value can be influenced by many factors that don't directly affect Henry Schein's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Henry Schein's value and its price as these two are different measures arrived at by different means. Investors typically determine if Henry Schein is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Henry Schein's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.